Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $27
Benzinga Newsdesk 3 days ago
Analyst RatingsNewsPrice Target
Citizens analyst Constantine Davides maintains NRC Health (NASDAQ:NRC) with a Market Outperform and raises the price target from $26 to $27.
Citizens analyst Constantine Davides maintains NRC Health (NASDAQ:NRC) with a Market Outperform and raises the price target from $26 to $27.